COVID-19 is an infectious disease caused by a virus named SARS-CoV-2, which first appeared in China in December 2019. The infection spread rapidly around the world and was declared a pandemic by WHO in March 2020. SARS-CoV-2 is mainly transmitted by aerosols during talking, breathing, coughing, or sneezing or being in close contact with an infected person. The incubation period is generally three to a maximum of 14 days. The symptoms and severity of SARS-CoV-19 infection can vary considerably. The most common symptoms include fever, cough, difficulty breathing, fatigue and loss of smell. In approximately 86% of all infected, the infection is mild to asymptomatic. However, especially in the elderly and those with pre-existing conditions, the virus can lead to severe respiratory diseases or pneumonia.
Early detection of SARS-CoV-2 is vital to provide the best possible care for patients and contact persons. This can also prevent the spread of this highly contagious virus. The PCR test is the earliest diagnostic marker for COVID-19. By extracting the carrier of genetic information (RNA) of the virus and subsequent detection by RT-PCR of several genes, unique and specific for SARS-CoV-2, GENICA provides results from a PCR test using the highest class laboratory analysis.
GENICA is under contract with the National Health Insurance Fund and accepts patients with a referral for „Polymerase chain reaction for the detection of COVID-19“ (PCR). Our lab also takes in electronic referrals for PCR test.
Find additional information and details about our SARS-CoV-2 test systems HERE.
Which COVID-19 test is the right for me?
GENICA offers a full range of test systems for the diagnosis of COVID-19 - from RT-PCR and antigen test for the diagnosis of current infection to serological tests for differentiated detection of different immunoglobulin classes antibodies and for different SARS-CoV-2 antigens.
The PCR test is the gold standard for diagnosing COVID-19. For symptomatic patients, the use of rapid antigen tests, which are also an indicator of ongoing infection, is acceptable. Antibodies tests are not an indication of an ongoing infection and are used exclusively to assess the body's immune response to the infection, indicating whether you have had COVID-19. For a comparative analysis of the application of the various tests for COVID-19, SEE HERE.
REVIEW OUR COVID-19 TESTS
COVID-19, flu or cold?
The ARVI test (Acute Respiratory Viral Infections) is a PCR test simultaneously detecting 22 pathogens associated with acute respiratory viral infections with similar symptoms to COVID 19. The test detects a number of respiratory viruses associated with influenza and non-influenza respiratory infections, differentiating them from SARS-CoV-2, which causes COVID-19. The ARVI test is performed on one sample - nasopharyngeal and oropharyngeal swab. For more information SEE HERE.
Of all the test systems, PCR analysis is recognized as the gold standard in the diagnosis of COVID-19.
PCR analysis is a molecular genetic method and is performed under different working protocols depending on the level of the laboratory. Standard laboratories follow simplified procedures, less sensitive to the test, whereas specialized genetic labs, such as GENICA, provide a high diagnostic class, highly sensitive PCR tests, assuring the accuracy and precision of the results.
GENICA’s RT-PCR test for SARS-CoV-2 by meets the high analytical criteria for a genetic laboratory and detects with high sensitivity unique and specific genes traceable only to this virus.
In partnership with other medical institutions GENICA Lab performs PCR sampling and antigen tests for COVID-19 at designated intake locations (the full list and business hours of COVID-19 intake locations can be found HERE). Samples for immunological tests for SARS-CoV-2 antibodies are accepted at all lab locations.
GENICA takes samples in the comfort of your home, letting you to return safely to your daily routines and loved ones.
Preregister and book an appointment for a home visit at https://web.genica.bg/public/appointment.
The visit is FREE of charge.
For the business to operate and grow under the increasing pandemic caring for the employees' health is paramount. Testing directly in your offices will allow you to ensure business continuity while maintaining the health of your employees. You save time, avoid waiting lines, minimize the possibility of contact with infected.
According to current WHO’s and the Centers for Disease Control and Prevention’s recommendations, the PCR POOL test is the most reliable and budget-friendly option for workplace screening /https://www.cdc.gov/coronavirus/2019-ncov/lab/pooling- procedures.html /.
What is a PCR POOL test?
The PCR POOL test is a group testing combining respiratory samples from several people and performing one lab test on the combined set of samples to detect SARS-CoV-2, the virus that causes COVID-19.
When is the PCR POOL test used?
Consolidation of samples allows labs to test more people at lower cost. The Centers for Disease Control and Prevention cites the PCR POOl test as the main tool for employees testing. The test is recommended for those companies applying prophylaxis and do not expect a high percentage of infected employees. The purpose of the test is to detect an infected employee as early as possible before the virus carrier is able to infect other people.
For more information: